784737002: Product containing precisely brompheniramine maleate 400 microgram/1 milliliter and dextromethorphan hydrobromide 2 milligram/1 milliliter and phenylpropanolamine hydrochloride 2.5 milligram/1 milliliter conventional release oral solution (clinical drug)

SNOMED CT Concept\Pharmaceutical / biologic product\Medicinal product\...

\Medicinal product categorised by disposition\Sigma-1 receptor agonist-containing product\Dextromethorphan-containing product\Brompheniramine- and dextromethorphan- and phenylpropanolamine-containing product\Brompheniramine and dextromethorphan and phenylpropanolamine only product\Brompheniramine and dextromethorphan and phenylpropanolamine only product in oral dose form\Brompheniramine maleate 400 microgram/mL and dextromethorphan hydrobromide 2 mg/mL and phenylpropanolamine hydrochloride 2.5 mg/mL oral solution
\Medicinal product categorised by disposition\Sigma-1 receptor agonist-containing product\Dextromethorphan-containing product\Brompheniramine- and dextromethorphan- and phenylpropanolamine-containing product\Brompheniramine- and dextromethorphan- and phenylpropanolamine-containing product in oral dose form\Brompheniramine and dextromethorphan and phenylpropanolamine only product in oral dose form\Brompheniramine maleate 400 microgram/mL and dextromethorphan hydrobromide 2 mg/mL and phenylpropanolamine hydrochloride 2.5 mg/mL oral solution
\Medicinal product categorised by disposition\Sigma-1 receptor agonist-containing product\Dextromethorphan-containing product\Dextromethorphan-containing product in oral dose form\Brompheniramine- and dextromethorphan- and phenylpropanolamine-containing product in oral dose form\Brompheniramine and dextromethorphan and phenylpropanolamine only product in oral dose form\Brompheniramine maleate 400 microgram/mL and dextromethorphan hydrobromide 2 mg/mL and phenylpropanolamine hydrochloride 2.5 mg/mL oral solution
\Medicinal product categorised by disposition\NMDA receptor antagonist-containing product\Dextromethorphan-containing product\Brompheniramine- and dextromethorphan- and phenylpropanolamine-containing product\Brompheniramine and dextromethorphan and phenylpropanolamine only product\Brompheniramine and dextromethorphan and phenylpropanolamine only product in oral dose form\Brompheniramine maleate 400 microgram/mL and dextromethorphan hydrobromide 2 mg/mL and phenylpropanolamine hydrochloride 2.5 mg/mL oral solution
\Medicinal product categorised by disposition\NMDA receptor antagonist-containing product\Dextromethorphan-containing product\Brompheniramine- and dextromethorphan- and phenylpropanolamine-containing product\Brompheniramine- and dextromethorphan- and phenylpropanolamine-containing product in oral dose form\Brompheniramine and dextromethorphan and phenylpropanolamine only product in oral dose form\Brompheniramine maleate 400 microgram/mL and dextromethorphan hydrobromide 2 mg/mL and phenylpropanolamine hydrochloride 2.5 mg/mL oral solution
\Medicinal product categorised by disposition\NMDA receptor antagonist-containing product\Dextromethorphan-containing product\Dextromethorphan-containing product in oral dose form\Brompheniramine- and dextromethorphan- and phenylpropanolamine-containing product in oral dose form\Brompheniramine and dextromethorphan and phenylpropanolamine only product in oral dose form\Brompheniramine maleate 400 microgram/mL and dextromethorphan hydrobromide 2 mg/mL and phenylpropanolamine hydrochloride 2.5 mg/mL oral solution
\Medicinal product categorised by disposition\Histamine receptor antagonist-containing product\Propylamine derivative histamine receptor antagonist product\Brompheniramine-containing product\Brompheniramine- and dextromethorphan- and phenylpropanolamine-containing product\Brompheniramine and dextromethorphan and phenylpropanolamine only product\Brompheniramine and dextromethorphan and phenylpropanolamine only product in oral dose form\Brompheniramine maleate 400 microgram/mL and dextromethorphan hydrobromide 2 mg/mL and phenylpropanolamine hydrochloride 2.5 mg/mL oral solution
\Medicinal product categorised by disposition\Histamine receptor antagonist-containing product\Propylamine derivative histamine receptor antagonist product\Brompheniramine-containing product\Brompheniramine- and dextromethorphan- and phenylpropanolamine-containing product\Brompheniramine- and dextromethorphan- and phenylpropanolamine-containing product in oral dose form\Brompheniramine and dextromethorphan and phenylpropanolamine only product in oral dose form\Brompheniramine maleate 400 microgram/mL and dextromethorphan hydrobromide 2 mg/mL and phenylpropanolamine hydrochloride 2.5 mg/mL oral solution
\Medicinal product categorised by disposition\Histamine receptor antagonist-containing product\Propylamine derivative histamine receptor antagonist product\Brompheniramine-containing product\Brompheniramine-containing product in oral dose form\Brompheniramine- and dextromethorphan- and phenylpropanolamine-containing product in oral dose form\Brompheniramine and dextromethorphan and phenylpropanolamine only product in oral dose form\Brompheniramine maleate 400 microgram/mL and dextromethorphan hydrobromide 2 mg/mL and phenylpropanolamine hydrochloride 2.5 mg/mL oral solution

\Medicinal product categorised by structure\Ether structure-containing product\Dextromethorphan-containing product\Brompheniramine- and dextromethorphan- and phenylpropanolamine-containing product\Brompheniramine and dextromethorphan and phenylpropanolamine only product\Brompheniramine and dextromethorphan and phenylpropanolamine only product in oral dose form\Brompheniramine maleate 400 microgram/mL and dextromethorphan hydrobromide 2 mg/mL and phenylpropanolamine hydrochloride 2.5 mg/mL oral solution
\Medicinal product categorised by structure\Ether structure-containing product\Dextromethorphan-containing product\Brompheniramine- and dextromethorphan- and phenylpropanolamine-containing product\Brompheniramine- and dextromethorphan- and phenylpropanolamine-containing product in oral dose form\Brompheniramine and dextromethorphan and phenylpropanolamine only product in oral dose form\Brompheniramine maleate 400 microgram/mL and dextromethorphan hydrobromide 2 mg/mL and phenylpropanolamine hydrochloride 2.5 mg/mL oral solution
\Medicinal product categorised by structure\Ether structure-containing product\Dextromethorphan-containing product\Dextromethorphan-containing product in oral dose form\Brompheniramine- and dextromethorphan- and phenylpropanolamine-containing product in oral dose form\Brompheniramine and dextromethorphan and phenylpropanolamine only product in oral dose form\Brompheniramine maleate 400 microgram/mL and dextromethorphan hydrobromide 2 mg/mL and phenylpropanolamine hydrochloride 2.5 mg/mL oral solution
\Medicinal product categorised by structure\Nitrogen and/or nitrogen compound-containing product\Propylamine-containing product\Propylamine derivative histamine receptor antagonist product\Brompheniramine-containing product\Brompheniramine- and dextromethorphan- and phenylpropanolamine-containing product\Brompheniramine and dextromethorphan and phenylpropanolamine only product\Brompheniramine and dextromethorphan and phenylpropanolamine only product in oral dose form\Brompheniramine maleate 400 microgram/mL and dextromethorphan hydrobromide 2 mg/mL and phenylpropanolamine hydrochloride 2.5 mg/mL oral solution
\Medicinal product categorised by structure\Nitrogen and/or nitrogen compound-containing product\Propylamine-containing product\Propylamine derivative histamine receptor antagonist product\Brompheniramine-containing product\Brompheniramine- and dextromethorphan- and phenylpropanolamine-containing product\Brompheniramine- and dextromethorphan- and phenylpropanolamine-containing product in oral dose form\Brompheniramine and dextromethorphan and phenylpropanolamine only product in oral dose form\Brompheniramine maleate 400 microgram/mL and dextromethorphan hydrobromide 2 mg/mL and phenylpropanolamine hydrochloride 2.5 mg/mL oral solution
\Medicinal product categorised by structure\Nitrogen and/or nitrogen compound-containing product\Propylamine-containing product\Propylamine derivative histamine receptor antagonist product\Brompheniramine-containing product\Brompheniramine-containing product in oral dose form\Brompheniramine- and dextromethorphan- and phenylpropanolamine-containing product in oral dose form\Brompheniramine and dextromethorphan and phenylpropanolamine only product in oral dose form\Brompheniramine maleate 400 microgram/mL and dextromethorphan hydrobromide 2 mg/mL and phenylpropanolamine hydrochloride 2.5 mg/mL oral solution
\Medicinal product categorised by structure\Nitrogen and/or nitrogen compound-containing product\Phenylpropanolamine-containing product\Brompheniramine- and dextromethorphan- and phenylpropanolamine-containing product\Brompheniramine and dextromethorphan and phenylpropanolamine only product\Brompheniramine and dextromethorphan and phenylpropanolamine only product in oral dose form\Brompheniramine maleate 400 microgram/mL and dextromethorphan hydrobromide 2 mg/mL and phenylpropanolamine hydrochloride 2.5 mg/mL oral solution
\Medicinal product categorised by structure\Nitrogen and/or nitrogen compound-containing product\Phenylpropanolamine-containing product\Brompheniramine- and dextromethorphan- and phenylpropanolamine-containing product\Brompheniramine- and dextromethorphan- and phenylpropanolamine-containing product in oral dose form\Brompheniramine and dextromethorphan and phenylpropanolamine only product in oral dose form\Brompheniramine maleate 400 microgram/mL and dextromethorphan hydrobromide 2 mg/mL and phenylpropanolamine hydrochloride 2.5 mg/mL oral solution
\Medicinal product categorised by structure\Nitrogen and/or nitrogen compound-containing product\Phenylpropanolamine-containing product\Phenylpropanolamine-containing product in oral dose form\Brompheniramine- and dextromethorphan- and phenylpropanolamine-containing product in oral dose form\Brompheniramine and dextromethorphan and phenylpropanolamine only product in oral dose form\Brompheniramine maleate 400 microgram/mL and dextromethorphan hydrobromide 2 mg/mL and phenylpropanolamine hydrochloride 2.5 mg/mL oral solution
\Medicinal product categorised by structure\Alcohol-containing product\Phenylpropanolamine-containing product\Brompheniramine- and dextromethorphan- and phenylpropanolamine-containing product\Brompheniramine and dextromethorphan and phenylpropanolamine only product\Brompheniramine and dextromethorphan and phenylpropanolamine only product in oral dose form\Brompheniramine maleate 400 microgram/mL and dextromethorphan hydrobromide 2 mg/mL and phenylpropanolamine hydrochloride 2.5 mg/mL oral solution
\Medicinal product categorised by structure\Alcohol-containing product\Phenylpropanolamine-containing product\Brompheniramine- and dextromethorphan- and phenylpropanolamine-containing product\Brompheniramine- and dextromethorphan- and phenylpropanolamine-containing product in oral dose form\Brompheniramine and dextromethorphan and phenylpropanolamine only product in oral dose form\Brompheniramine maleate 400 microgram/mL and dextromethorphan hydrobromide 2 mg/mL and phenylpropanolamine hydrochloride 2.5 mg/mL oral solution
\Medicinal product categorised by structure\Alcohol-containing product\Phenylpropanolamine-containing product\Phenylpropanolamine-containing product in oral dose form\Brompheniramine- and dextromethorphan- and phenylpropanolamine-containing product in oral dose form\Brompheniramine and dextromethorphan and phenylpropanolamine only product in oral dose form\Brompheniramine maleate 400 microgram/mL and dextromethorphan hydrobromide 2 mg/mL and phenylpropanolamine hydrochloride 2.5 mg/mL oral solution

\Medicinal product categorised by therapeutic role\Antitussive agent\Dextromethorphan-containing product\...

\Brompheniramine- and dextromethorphan- and phenylpropanolamine-containing product\Brompheniramine and dextromethorphan and phenylpropanolamine only product\Brompheniramine and dextromethorphan and phenylpropanolamine only product in oral dose form\Brompheniramine maleate 400 microgram/mL and dextromethorphan hydrobromide 2 mg/mL and phenylpropanolamine hydrochloride 2.5 mg/mL oral solution
\Brompheniramine- and dextromethorphan- and phenylpropanolamine-containing product\Brompheniramine- and dextromethorphan- and phenylpropanolamine-containing product in oral dose form\Brompheniramine and dextromethorphan and phenylpropanolamine only product in oral dose form\Brompheniramine maleate 400 microgram/mL and dextromethorphan hydrobromide 2 mg/mL and phenylpropanolamine hydrochloride 2.5 mg/mL oral solution

\Dextromethorphan-containing product in oral dose form\Brompheniramine- and dextromethorphan- and phenylpropanolamine-containing product in oral dose form\Brompheniramine and dextromethorphan and phenylpropanolamine only product in oral dose form\Brompheniramine maleate 400 microgram/mL and dextromethorphan hydrobromide 2 mg/mL and phenylpropanolamine hydrochloride 2.5 mg/mL oral solution

\Product manufactured as oral dose form\Dextromethorphan-containing product in oral dose form\Brompheniramine- and dextromethorphan- and phenylpropanolamine-containing product in oral dose form\Brompheniramine and dextromethorphan and phenylpropanolamine only product in oral dose form\Brompheniramine maleate 400 microgram/mL and dextromethorphan hydrobromide 2 mg/mL and phenylpropanolamine hydrochloride 2.5 mg/mL oral solution
\Product manufactured as oral dose form\Phenylpropanolamine-containing product in oral dose form\Brompheniramine- and dextromethorphan- and phenylpropanolamine-containing product in oral dose form\Brompheniramine and dextromethorphan and phenylpropanolamine only product in oral dose form\Brompheniramine maleate 400 microgram/mL and dextromethorphan hydrobromide 2 mg/mL and phenylpropanolamine hydrochloride 2.5 mg/mL oral solution
\Product manufactured as oral dose form\Brompheniramine-containing product in oral dose form\Brompheniramine- and dextromethorphan- and phenylpropanolamine-containing product in oral dose form\Brompheniramine and dextromethorphan and phenylpropanolamine only product in oral dose form\Brompheniramine maleate 400 microgram/mL and dextromethorphan hydrobromide 2 mg/mL and phenylpropanolamine hydrochloride 2.5 mg/mL oral solution

\Autonomic agent\Sympathomimetic-containing product\Phenylpropanolamine-containing product\...

\Brompheniramine- and dextromethorphan- and phenylpropanolamine-containing product\Brompheniramine and dextromethorphan and phenylpropanolamine only product\Brompheniramine and dextromethorphan and phenylpropanolamine only product in oral dose form\Brompheniramine maleate 400 microgram/mL and dextromethorphan hydrobromide 2 mg/mL and phenylpropanolamine hydrochloride 2.5 mg/mL oral solution
\Brompheniramine- and dextromethorphan- and phenylpropanolamine-containing product\Brompheniramine- and dextromethorphan- and phenylpropanolamine-containing product in oral dose form\Brompheniramine and dextromethorphan and phenylpropanolamine only product in oral dose form\Brompheniramine maleate 400 microgram/mL and dextromethorphan hydrobromide 2 mg/mL and phenylpropanolamine hydrochloride 2.5 mg/mL oral solution

\Phenylpropanolamine-containing product in oral dose form\Brompheniramine- and dextromethorphan- and phenylpropanolamine-containing product in oral dose form\Brompheniramine and dextromethorphan and phenylpropanolamine only product in oral dose form\Brompheniramine maleate 400 microgram/mL and dextromethorphan hydrobromide 2 mg/mL and phenylpropanolamine hydrochloride 2.5 mg/mL oral solution

Status: current, Defined. Date: 31-Jul 2019. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

3765363017 Product containing precisely brompheniramine maleate 400 microgram/1 milliliter and dextromethorphan hydrobromide 2 milligram/1 milliliter and phenylpropanolamine hydrochloride 2.5 milligram/1 milliliter conventional release oral solution (clinical drug) en Fully specified name Active Case insensitive SNOMED CT core

3765364011 Brompheniramine maleate 400 microgram/mL and dextromethorphan hydrobromide 2 mg/mL and phenylpropanolamine hydrochloride 2.5 mg/mL oral solution en Synonym Active Initial character case insensitive SNOMED CT core

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Brompheniramine maleate 400 microgram/mL and dextromethorphan hydrobromide 2 mg/mL and phenylpropanolamine hydrochloride 2.5 mg/mL oral solution	Has manufactured dose form	Oral solution	true	Inferred relationship	Some
Brompheniramine maleate 400 microgram/mL and dextromethorphan hydrobromide 2 mg/mL and phenylpropanolamine hydrochloride 2.5 mg/mL oral solution	Has concentration strength denominator value	1	false	Inferred relationship	Some	3
Brompheniramine maleate 400 microgram/mL and dextromethorphan hydrobromide 2 mg/mL and phenylpropanolamine hydrochloride 2.5 mg/mL oral solution	Has concentration strength denominator unit	mL	true	Inferred relationship	Some	3
Brompheniramine maleate 400 microgram/mL and dextromethorphan hydrobromide 2 mg/mL and phenylpropanolamine hydrochloride 2.5 mg/mL oral solution	Has concentration strength denominator unit	mL	true	Inferred relationship	Some	2
Brompheniramine maleate 400 microgram/mL and dextromethorphan hydrobromide 2 mg/mL and phenylpropanolamine hydrochloride 2.5 mg/mL oral solution	Has concentration strength denominator unit	mL	true	Inferred relationship	Some	1
Brompheniramine maleate 400 microgram/mL and dextromethorphan hydrobromide 2 mg/mL and phenylpropanolamine hydrochloride 2.5 mg/mL oral solution	Has concentration strength denominator value	1	false	Inferred relationship	Some	2
Brompheniramine maleate 400 microgram/mL and dextromethorphan hydrobromide 2 mg/mL and phenylpropanolamine hydrochloride 2.5 mg/mL oral solution	Has concentration strength numerator unit	mg	true	Inferred relationship	Some	2
Brompheniramine maleate 400 microgram/mL and dextromethorphan hydrobromide 2 mg/mL and phenylpropanolamine hydrochloride 2.5 mg/mL oral solution	Has concentration strength denominator value	1	false	Inferred relationship	Some	1
Brompheniramine maleate 400 microgram/mL and dextromethorphan hydrobromide 2 mg/mL and phenylpropanolamine hydrochloride 2.5 mg/mL oral solution	Count of base of active ingredient	3	false	Inferred relationship	Some
Brompheniramine maleate 400 microgram/mL and dextromethorphan hydrobromide 2 mg/mL and phenylpropanolamine hydrochloride 2.5 mg/mL oral solution	Is a	Brompheniramine and dextromethorphan and phenylpropanolamine only product in oral dose form	true	Inferred relationship	Some
Brompheniramine maleate 400 microgram/mL and dextromethorphan hydrobromide 2 mg/mL and phenylpropanolamine hydrochloride 2.5 mg/mL oral solution	Has concentration strength numerator value	2	false	Inferred relationship	Some	2
Brompheniramine maleate 400 microgram/mL and dextromethorphan hydrobromide 2 mg/mL and phenylpropanolamine hydrochloride 2.5 mg/mL oral solution	Has concentration strength numerator unit	mg	true	Inferred relationship	Some	3
Brompheniramine maleate 400 microgram/mL and dextromethorphan hydrobromide 2 mg/mL and phenylpropanolamine hydrochloride 2.5 mg/mL oral solution	Has concentration strength numerator value	2.5	false	Inferred relationship	Some	3
Brompheniramine maleate 400 microgram/mL and dextromethorphan hydrobromide 2 mg/mL and phenylpropanolamine hydrochloride 2.5 mg/mL oral solution	Has BoSS	Phenylpropanolamine hydrochloride	true	Inferred relationship	Some	3
Brompheniramine maleate 400 microgram/mL and dextromethorphan hydrobromide 2 mg/mL and phenylpropanolamine hydrochloride 2.5 mg/mL oral solution	Has precise active ingredient	Dextromethorphan hydrobromide	true	Inferred relationship	Some	2
Brompheniramine maleate 400 microgram/mL and dextromethorphan hydrobromide 2 mg/mL and phenylpropanolamine hydrochloride 2.5 mg/mL oral solution	Has BoSS	Dextromethorphan hydrobromide	true	Inferred relationship	Some	2
Brompheniramine maleate 400 microgram/mL and dextromethorphan hydrobromide 2 mg/mL and phenylpropanolamine hydrochloride 2.5 mg/mL oral solution	Has concentration strength numerator unit	mcg	true	Inferred relationship	Some	1
Brompheniramine maleate 400 microgram/mL and dextromethorphan hydrobromide 2 mg/mL and phenylpropanolamine hydrochloride 2.5 mg/mL oral solution	Has precise active ingredient	Brompheniramine maleate	true	Inferred relationship	Some	1
Brompheniramine maleate 400 microgram/mL and dextromethorphan hydrobromide 2 mg/mL and phenylpropanolamine hydrochloride 2.5 mg/mL oral solution	Has precise active ingredient	Phenylpropanolamine hydrochloride	true	Inferred relationship	Some	3
Brompheniramine maleate 400 microgram/mL and dextromethorphan hydrobromide 2 mg/mL and phenylpropanolamine hydrochloride 2.5 mg/mL oral solution	Has BoSS	Brompheniramine maleate	true	Inferred relationship	Some	1
Brompheniramine maleate 400 microgram/mL and dextromethorphan hydrobromide 2 mg/mL and phenylpropanolamine hydrochloride 2.5 mg/mL oral solution	Has concentration strength numerator value	400	false	Inferred relationship	Some	1
Brompheniramine maleate 400 microgram/mL and dextromethorphan hydrobromide 2 mg/mL and phenylpropanolamine hydrochloride 2.5 mg/mL oral solution	Plays role	Antitussive therapeutic role	true	Inferred relationship	Some

Inbound Relationships

Type

Active

Source

Characteristic

Refinability

Group

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
3765363017	Product containing precisely brompheniramine maleate 400 microgram/1 milliliter and dextromethorphan hydrobromide 2 milligram/1 milliliter and phenylpropanolamine hydrochloride 2.5 milligram/1 milliliter conventional release oral solution (clinical drug)	en	Fully specified name	Active	Case insensitive	SNOMED CT core
3765364011	Brompheniramine maleate 400 microgram/mL and dextromethorphan hydrobromide 2 mg/mL and phenylpropanolamine hydrochloride 2.5 mg/mL oral solution	en	Synonym	Active	Initial character case insensitive	SNOMED CT core